CLINICAL_TRIALS ClinicalTrials.gov record update

Effectiveness of HEPA-filtered Rooms ("Protected Environment") to Prevent Morbidity and Mortality in Patients Age >/ = 60 Receiving Lower Intensity ("Targeted") Therapy for Untreated AML and High-risk Myelodysplasia (MDS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00443300
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:17.604277+00:00
Published At: 2012-08-02T00:00:00+00:00
Record Updated At: 2012-08-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myelogenous Leukemia", "Myelodysplastic Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-08-02"
protocolSection.identificationModule.nctId: "NCT00443300"
protocolSection.identificationModule.officialTitle: "Effectiveness of HEPA-filtered Rooms (\"Protected Environment\") to Prevent Morbidity and Mortality in Patients Age \u003e/ = 60 Receiving Lower Intensity (\"Targeted\") Therapy for Untreated AML and High-risk Myelodysplasia (MDS)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.